Benjamin Glicksberg, PhD
- ASSISTANT PROFESSOR | Genetics and Genomic Sciences
Research Topics:
Alzheimer's Disease, Bioinformatics, Biomedical Informatics, Biomedical Sciences, Biostatistics, Cardiovascular, Computational Biology, Computer Simulation, Electrophysiology, Epidemiology, Genetics, Genomics, Imaging, MRI, Magnetic Resonance ImagingBenjamin Glicksberg, PhD is an Assistant Professor of Genetics and Genomic Sciences and a member of the Hasso Plattner Institute for Digital Health at the Icahn School of Medicine at Mount Sinai. Dr. Glicksberg has extensive experience in clinical informatics and work involving Electronic Health Record data. He uses machine learning to couple multi-omic patient health data to forward personalized medicine. He completed his PhD in Neuroscience at the Icahn School of Medicine at Mount Sinai in 2017 and post-doctoral work at the University of California, San Francisco in 2019.
Multi-Disciplinary Training Area
Genetics and Data Science [GDS]Education
PhD, Icahn School of Medicine at Mount Sinai
Post-doctoral, University of Califnornia, San Francisco
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Glicksberg during 2019 and/or 2020. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Sema4; University of California, San Francisco (UCSF)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.